CLINICAL TRIALS PROFILE FOR TICARCILLIN DISODIUM
✉ Email this page to a colleague
All Clinical Trials for ticarcillin disodium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01229046 ↗ | Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants | Withdrawn | Phillip Brian Smith | Phase 1 | 2010-09-01 | This study will evaluate the safety, tolerability and PK of ticarcillin-clavulanate in infants <91 days of age with suspected systemic infection. |
NCT02017197 ↗ | Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil | Completed | Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 | 2014-08-01 | The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks. |
NCT02017197 ↗ | Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil | Completed | Federal University of São Paulo | Phase 4 | 2014-08-01 | The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ticarcillin disodium
Condition Name
Clinical Trial Locations for ticarcillin disodium
Trials by Country
Clinical Trial Progress for ticarcillin disodium
Clinical Trial Phase
Clinical Trial Sponsors for ticarcillin disodium
Sponsor Name